Phase 3 Temporal Lobe Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
Mesial Temporal Lobe Epilepsy
Neurona Therapeutics88 enrolled35 locationsNCT05135091
Recruiting
Phase 3
Anterior Temporal Lobectomy in Temporal Glioblastoma
Newly Diagnosed GlioblastomaTemporal Lobe
University Hospital, Bonn178 enrolled1 locationNCT07021339